Is Viavi Solutions Stock a Buy or Sell After Its CEO Dumps Shares Worth More Than $1 Million

Viavi CEO Oleg Khaykin executed open-market sales of 73,442 shares on Dec. 3–4, 2025 (weighted avg price $17.36) for roughly $1.3M, leaving him with 1,921,191 directly held shares (~$33.6M post-sale); the stock closed at $17.50 on Dec. 4 and reached a 52-week high of $18.55 on Dec. 5. Viavi, with a $3.91B market cap and TTM revenue of $1.15B (FY25 revenue $1.08B; fiscal Q1 sales $299.1M, +26% YoY), is benefiting from data-center/AI-related demand, but its valuation (P/E >200) tempers near-term upside despite strong recent performance.

Analysis

Market structure: Viavi (VIAV) is a near-term beneficiary of AI/data‑center optical test demand and rising OSP spend; winners include optical component suppliers and data‑center test vendors while slower legacy telecom capex names could lose share. The CEO sale (3.7% of direct holdings) is small relative to total ownership (0.86% outstanding) and likely redistribution/tax-taking after a 68% YTD move, so market structure impact is more sentimentary than supply‑driven. Options IV and short‑dated call demand will likely compress if momentum stalls; bond spreads and FX are immaterial at this capitalization ($3.9B).

Risk assessment: Tail risks include a rapid AI capex pullback (20–30% budget cut → >15% revenue downside year‑over‑year), loss of a top‑10 customer, or export/regulatory restrictions on optical/security products. Immediate (days): modest negative sentiment from insider sales; short term (weeks–months): re‑rating around guidance and deliveries; long term (12–36 months): secular demand for optical test could validate higher earnings, but current P/E >200 requires execution. Hidden dependencies: customer concentration, backlog recognition, and govt procurement cycles.

Trade implications: Preferred setup is defined‑risk exposure: (A) establish 2% portfolio long VIAV on pullback to $14–15 (≈‑15–20%) with stop at $12; target 30–50% upside in 12–24 months. (B) If no pullback, buy a March 2026 15/20 call spread (limited debit, 1% allocation) to play AI tailwinds. (C) Harvest premium by selling 30–45 day covered calls at $20 if holding stock until next earnings.

Contrarian angles: Consensus fixates on insider sales and high P/E but underweights durable OSP demand from AI and aerospace/defense orders; if Viavi converts 20–30% incremental DC TAM, EPS inflection could be 12–24 months out. Reaction may be underdone if management continues strong bookings; conversely, a disappointing guide would be a swift 25–35% downside, so size positions accordingly and prefer option‑defined risk.

Key Decisions for Investors

• Establish a 2% portfolio long position in VIAV on weakness to $14.00–$15.00 (≈15–20% drawdown from $17.50). Set a stop-loss at $12 and target 30–50% upside over 12–24 months; reassess at each quarterly report.
• If no pullback, allocate 1% to a defined‑risk March 2026 VIAV 15/20 call spread to capture upside from AI/data‑center demand; close or roll if spread value doubles or after the March earnings print.
• If long shares, sell 30–45 day covered calls at the $20 strike to generate yield until the next earnings cycle; size such that maximum assignment risk is acceptable (e.g., cover no more than 50% of long position).
• Initiate a relative‑value pair: long VIAV 2% vs short KEYS 1.5% (or a larger test‑equipment peer) to express idiosyncratic upside in optical/DC exposure while hedging broad test‑equipment cyclicality; rebalance if spread moves >10% either direction.
• Monitor bookings and customer concentration metrics in next 30–60 days (quarterly guide and top‑5 customer revenue disclosure). If bookings miss by >10% QoQ or management withdraws guidance, reduce net exposure by 50% within 5 trading days.